XOMA Royalty (XOMA) Interest Coverage Ratio (2011 - 2026)
XOMA Royalty (XOMA) reported Interest Coverage Ratio of 0.02 for Q1 2026, down 102.34% on a YoY basis from 0.93 in Q1 2025, and down 107.41% sequentially from 0.29 in Q2 2025.
XOMA Royalty (XOMA) Interest Coverage Ratio (2011 - 2026) Analysis & Trends
XOMA Royalty (XOMA) has 16 years of Interest Coverage Ratio data on file, last reported at 0.02 in Q1 2026.
- For the quarter ending Q1 2026, Interest Coverage Ratio fell 102.34% year-over-year to 0.02; the trailing twelve-month figure through Mar 2026 stood at 0.55 (up 128.62% YoY), and the FY2025 full-year result was 0.07, up 115.16% from the prior year.
- Interest Coverage Ratio declined to 0.02 in Q1 2026, from 0.29 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.93 in Q1 2025 to a low of 121.76 in Q4 2022.
- A 5-year average of 15.25 and a median of 0.77 in 2024 frame the typical range for Interest Coverage Ratio.
- Across the five-year window, Interest Coverage Ratio slumped 221.14% in 2022 and surged 150.0% in 2025, its largest moves.
- Tracing XOMA's Interest Coverage Ratio over 5 years: stood at 121.76 in 2022, then surged by 60.46% to 48.15 in 2023, then jumped by 95.56% to 2.14 in 2024, then soared by 113.71% to 0.29 in 2025, then plunged by 107.41% to 0.02 in 2026.
- Business Quant data shows XOMA's Interest Coverage Ratio at 0.02 in Q1 2026, 0.29 in Q2 2025, and 0.93 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 658.42 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 7.60 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -0.22 |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 2.71 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 22.72 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -0.38 |
| 10 | XOMA Royalty | 478.42 Mn | 412.34 Mn | - | -0.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.02 |
| Jun 30, 2025 | 0.29 |
| Mar 31, 2025 | 0.93 |
| Dec 31, 2024 | -2.14 |
| Sep 30, 2024 | -0.77 |
| Jun 30, 2024 | -0.59 |
| Mar 31, 2024 | -1.85 |
| Dec 31, 2023 | -48.15 |
| Sep 30, 2023 | -0.85 |
| Jun 30, 2023 | -0.52 |
| Mar 31, 2023 | -11.34 |
| Dec 31, 2022 | -121.76 |
| Sep 30, 2022 | -0.43 |
| Jun 30, 2022 | -0.30 |
| Mar 31, 2022 | -41.30 |
| Dec 31, 2021 | 619.69 |
| Sep 30, 2021 | -0.17 |
| Jun 30, 2021 | -0.09 |
| Mar 31, 2021 | -22.24 |
| Dec 31, 2020 | 497.33 |